BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27895094)

  • 1. Crosstalk between microRNA-122 and FOX family genes in HepG2 cells.
    Kumar S; Batra A; Kanthaje S; Ghosh S; Chakraborti A
    Exp Biol Med (Maywood); 2017 Feb; 242(4):436-440. PubMed ID: 27895094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of miR-377 contributes to IRX3 deregulation in hepatocellular carcinoma.
    Wang P; Zhuang C; Huang D; Xu K
    Oncol Rep; 2016 Jul; 36(1):247-52. PubMed ID: 27222047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA circ-FOXP1 induced by SOX9 promotes hepatocellular carcinoma progression via sponging miR-875-3p and miR-421.
    Wang W; Li Y; Li X; Liu B; Han S; Li X; Zhang B; Li J; Sun S
    Biomed Pharmacother; 2020 Jan; 121():109517. PubMed ID: 31698267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-216b is downregulated in hepatocellular carcinoma and inhibits HepG2 cell growth by targeting Forkhead box protein M1.
    Zheng WW; Zhou J; Zhang CH; Liu XS
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(12):2541-50. PubMed ID: 27383303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downreguation of FoxM1 by miR-214 inhibits proliferation and migration in hepatocellular carcinoma.
    Tian C; Wu H; Li C; Tian X; Sun Y; Liu E; Liao X; Song W
    Gene Ther; 2018 Jul; 25(4):312-319. PubMed ID: 29973656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-608 inhibits human hepatocellular carcinoma cell proliferation via targeting the BET family protein BRD4.
    He L; Meng D; Zhang SH; Zhang Y; Deng Z; Kong LB
    Biochem Biophys Res Commun; 2018 Jul; 501(4):1060-1067. PubMed ID: 29777702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of miR-877 induced by paclitaxel inhibits hepatocellular carcinoma cell proliferation though targeting FOXM1.
    Huang X; Qin J; Lu S
    Int J Clin Exp Pathol; 2015; 8(2):1515-24. PubMed ID: 25973036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-592 targets DEK oncogene and suppresses cell growth in the hepatocellular carcinoma cell line HepG2.
    Li X; Zhang W; Zhou L; Yue D; Su X
    Int J Clin Exp Pathol; 2015; 8(10):12455-63. PubMed ID: 26722432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-152-5p inhibits proliferation and induces apoptosis of liver cancer cells by up-regulating FOXO expression.
    Chang DL; Wei W; Yu ZP; Qin CK
    Pharmazie; 2017 Jun; 72(6):338-343. PubMed ID: 29442022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-338-3p inhibits cell proliferation in hepatocellular carcinoma by target forkhead box P4 (FOXP4).
    Wang G; Sun Y; He Y; Ji C; Hu B; Sun Y
    Int J Clin Exp Pathol; 2015; 8(1):337-44. PubMed ID: 25755720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of miR-329 promotes cell invasion by regulating BRD4 and predicts poor prognosis in hepatocellular carcinoma.
    Zhou J; Li W; Guo J; Li G; Chen F; Zhou J
    Tumour Biol; 2016 Mar; 37(3):3561-9. PubMed ID: 26456956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
    Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
    Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma.
    Zhu C; Zhou R; Zhou Q; Chang Y; Jiang M
    Life Sci; 2016 Dec; 166():34-40. PubMed ID: 27717846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4.
    Zhao Y; Li F; Zhang X; Liu A; Qi J; Cui H; Zhao P
    Int J Clin Exp Pathol; 2015; 8(10):12446-54. PubMed ID: 26722431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.
    Chen L; Guan H; Gu C; Cao Y; Shao J; Wang F
    Tumour Biol; 2016 Feb; 37(2):2497-507. PubMed ID: 26385772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-21 promotes cell proliferation in human hepatocellular carcinoma partly by targeting HEPN1.
    Hu S; Tao R; Wang S; Wang C; Zhao X; Zhao H; Li L; Zhu S; He Y; Jiang X; Gao Y
    Tumour Biol; 2015 Jul; 36(7):5467-72. PubMed ID: 25687183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. USP39 promotes the growth of human hepatocellular carcinoma in vitro and in vivo.
    Yuan X; Sun X; Shi X; Jiang C; Yu D; Zhang W; Guan W; Zhou J; Wu Y; Qiu Y; Ding Y
    Oncol Rep; 2015 Aug; 34(2):823-32. PubMed ID: 26081192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of tumorigenesis and metastasis of hepatocellular carcinoma tumor endothelial cells by microRNA-3178 and underlying mechanism.
    Li W; Shen S; Wu S; Chen Z; Hu C; Yan R
    Biochem Biophys Res Commun; 2015 Aug; 464(3):881-7. PubMed ID: 26182877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effects of miR-101 on prognosis of hepatocellular carcinoma and carcinogenic mechanism of anti-miR-101.
    Lv X; Li J; Yang B
    Oncol Rep; 2016 Oct; 36(4):2184-92. PubMed ID: 27498785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.